View in EDS

Cardiovascular consequences of discontinuing low-dose rivaroxaban in people with chronic coronary or peripheral artery disease.

Saved in:
Bibliographic Details
Title: Cardiovascular consequences of discontinuing low-dose rivaroxaban in people with chronic coronary or peripheral artery disease.
Authors: Dagenais GR; Department of Cardiology, Laval University Heart and Lung Institute, Quebec, Québec, Canada gilles.dagenais@criucpq.ulaval.ca., Dyal L; Population Health Research Institute, Hamilton Health Sciences/McMaster University, Hamilton, Ontario, Canada., Bosch JJ; Population Health Research Institute, Hamilton Health Sciences/McMaster University, Hamilton, Ontario, Canada., Leong DP; Population Health Research Institute, Hamilton Health Sciences/McMaster University, Hamilton, Ontario, Canada., Aboyans V; Department of Cardiology, Dupuytren University Hospital, Limoges, France.; Department of Cardiology, INSERM, U1094, Tropical Neuroepidemiology, Limoges, France., Berkowitz SD; Bayer HealthCare Pharmaceuticals, Whippany, New Jersey, USA., Bhatt DL; Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School, Boston, Massachusetts, USA., Connolly SJ; Population Health Research Institute, Hamilton Health Sciences/McMaster University, Hamilton, Ontario, Canada., Fox KAA; Department of Medicine, University of Edinburgh, Edinburgh, UK., Muehlhofer E; Bayer HealthCare Pharmaceuticals, Whippany, New Jersey, USA., Probstfield JL; Department of Medicine (Cardiology), University of Washington Medical Centre, Seattle, Washington, USA., Widimsky P; Cardiocenter, University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University Prague, Prague, Czech Republic., Winkelmann BR; Kardiologische Studienpraxis und ClinPhenomics GmbH&Co, Studienzentrum Schaumainkai Frankfurt, Frankfurt, Germany., Yusuf S; Population Health Research Institute, Hamilton Health Sciences/McMaster University, Hamilton, Ontario, Canada., Eikelboom JW; Population Health Research Institute, Hamilton Health Sciences/McMaster University, Hamilton, Ontario, Canada.
Source: Heart (British Cardiac Society) [Heart] 2021 Jul; Vol. 107 (14), pp. 1130-1137. Date of Electronic Publication: 2021 May 21.
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 9602087 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-201X (Electronic) Linking ISSN: 13556037 NLM ISO Abbreviation: Heart Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34021038
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cardiovascular consequences of discontinuing low-dose rivaroxaban in people with chronic coronary or peripheral artery disease.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Dagenais+GR%22">Dagenais GR</searchLink>; Department of Cardiology, Laval University Heart and Lung Institute, Quebec, Québec, Canada gilles.dagenais@criucpq.ulaval.ca.<br /><searchLink fieldCode="AU" term="%22Dyal+L%22">Dyal L</searchLink>; Population Health Research Institute, Hamilton Health Sciences/McMaster University, Hamilton, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Bosch+JJ%22">Bosch JJ</searchLink>; Population Health Research Institute, Hamilton Health Sciences/McMaster University, Hamilton, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Leong+DP%22">Leong DP</searchLink>; Population Health Research Institute, Hamilton Health Sciences/McMaster University, Hamilton, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Aboyans+V%22">Aboyans V</searchLink>; Department of Cardiology, Dupuytren University Hospital, Limoges, France.; Department of Cardiology, INSERM, U1094, Tropical Neuroepidemiology, Limoges, France.<br /><searchLink fieldCode="AU" term="%22Berkowitz+SD%22">Berkowitz SD</searchLink>; Bayer HealthCare Pharmaceuticals, Whippany, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Bhatt+DL%22">Bhatt DL</searchLink>; Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Connolly+SJ%22">Connolly SJ</searchLink>; Population Health Research Institute, Hamilton Health Sciences/McMaster University, Hamilton, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Fox+KAA%22">Fox KAA</searchLink>; Department of Medicine, University of Edinburgh, Edinburgh, UK.<br /><searchLink fieldCode="AU" term="%22Muehlhofer+E%22">Muehlhofer E</searchLink>; Bayer HealthCare Pharmaceuticals, Whippany, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Probstfield+JL%22">Probstfield JL</searchLink>; Department of Medicine (Cardiology), University of Washington Medical Centre, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Widimsky+P%22">Widimsky P</searchLink>; Cardiocenter, University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University Prague, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Winkelmann+BR%22">Winkelmann BR</searchLink>; Kardiologische Studienpraxis und ClinPhenomics GmbH&Co, Studienzentrum Schaumainkai Frankfurt, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Yusuf+S%22">Yusuf S</searchLink>; Population Health Research Institute, Hamilton Health Sciences/McMaster University, Hamilton, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Eikelboom+JW%22">Eikelboom JW</searchLink>; Population Health Research Institute, Hamilton Health Sciences/McMaster University, Hamilton, Ontario, Canada.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229602087%22">Heart (British Cardiac Society)</searchLink> [Heart] 2021 Jul; Vol. 107 (14), pp. 1130-1137. <i>Date of Electronic Publication: </i>2021 May 21.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Pub%2E+Group%22">BMJ Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9602087 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1468-201X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213556037%22">13556037 </searchLink><i>NLM ISO Abbreviation: </i>Heart <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34021038
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1136/heartjnl-2020-318758
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1130
    Titles:
      – TitleFull: Cardiovascular consequences of discontinuing low-dose rivaroxaban in people with chronic coronary or peripheral artery disease.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Dagenais GR
      – PersonEntity:
          Name:
            NameFull: Dyal L
      – PersonEntity:
          Name:
            NameFull: Bosch JJ
      – PersonEntity:
          Name:
            NameFull: Leong DP
      – PersonEntity:
          Name:
            NameFull: Aboyans V
      – PersonEntity:
          Name:
            NameFull: Berkowitz SD
      – PersonEntity:
          Name:
            NameFull: Bhatt DL
      – PersonEntity:
          Name:
            NameFull: Connolly SJ
      – PersonEntity:
          Name:
            NameFull: Fox KAA
      – PersonEntity:
          Name:
            NameFull: Muehlhofer E
      – PersonEntity:
          Name:
            NameFull: Probstfield JL
      – PersonEntity:
          Name:
            NameFull: Widimsky P
      – PersonEntity:
          Name:
            NameFull: Winkelmann BR
      – PersonEntity:
          Name:
            NameFull: Yusuf S
      – PersonEntity:
          Name:
            NameFull: Eikelboom JW
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2021 Jul
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1468-201X
          Numbering:
            – Type: volume
              Value: 107
            – Type: issue
              Value: 14
          Titles:
            – TitleFull: Heart (British Cardiac Society)
              Type: main
ResultId 1